Linking Outcomes Management to Quality-of-Life Measurement

ONCOLOGY

Volumn 11, Issue 11 SUPPL. 11A, 1997, Pages 232-235

  Cella, David ^a   Webster, Kimberly ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; FATIGUE; HUMAN; QUALITY OF LIFE; TREATMENT OUTCOME;

COHORT STUDIES; FATIGUE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE;

EID: 0031264467     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Goodyear MDE, Fraumeni MA: Incorporating quality of life assessment into clinical cancer trials, in Spilker B (ed): Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed, pp 1003-1014. Philadelphia, Lippincott-Raven, 1996.
2. Revicki DA, Cella DF: Health status assessment for the twenty first century: Item response theory, item banking and computer adaptive testing. Qual Life Res 6(6):595-600, 1997.
3. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. J Clin Oncol 11(3):570-579, 1993.
4. Cella DF, Bonomi AE: Measuring quality of life today: 1995 update. Oncology 9(11):47-60, 1995.
5. Yellen SB, Cella DF, Webster K, et al: Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Management 13(2):63-74, 1997.
6. Cella D: The FACT-An scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Proceedings of the American Society of Hematology, Orlando, Florida, 1996.
7. Cella D: The Functional Assessment of Cancer Therapy-Anemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Oncol 34(3): 13-19, 1997.
8. Glaspy J, Bukowski R, Steinberg D, et al: Impact of therapy with epoetin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice: Procrit ® Study Group. J Clin Oncol 15(3):1218-1234, 1997.